Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 2
1958 1
1977 1
1978 1
1981 3
1982 4
1983 4
1984 1
1985 3
1986 1
1987 4
1988 1
1990 5
1991 3
1992 6
1993 8
1994 12
1995 11
1996 6
1997 7
1998 9
1999 13
2000 8
2001 16
2002 13
2003 16
2004 27
2005 18
2006 31
2007 36
2008 46
2009 45
2010 36
2011 53
2012 61
2013 59
2014 76
2015 94
2016 97
2017 110
2018 103
2019 107
2020 132
2021 137
2022 93
Text availability
Article attribute
Article type
Publication date

Search Results

1,351 results
Results by year
Filters applied: . Clear all
Page 1
Ketamine for depression clinical issues.
Iqbal SZ, Mathew SJ. Iqbal SZ, et al. Among authors: mathew sj. Adv Pharmacol. 2020;89:131-162. doi: 10.1016/bs.apha.2020.02.005. Epub 2020 Apr 1. Adv Pharmacol. 2020. PMID: 32616205 Review.
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP. Bartlett NL, et al. Among authors: mathew s. J Clin Oncol. 2019 Jul 20;37(21):1790-1799. doi: 10.1200/JCO.18.01994. Epub 2019 Apr 2. J Clin Oncol. 2019. PMID: 30939090 Free PMC article. Clinical Trial.
ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
Mathew SJ, Wilkinson ST, Altinay M, Asghar-Ali A, Chang LC, Collins KA, Dale RM, Hu B, Krishnan K, Kellner CH, Malone DA, Murrough JW, Ostroff RB, Sanacora G, Shao M, Anand A. Mathew SJ, et al. Contemp Clin Trials. 2019 Feb;77:19-26. doi: 10.1016/j.cct.2018.12.009. Epub 2018 Dec 17. Contemp Clin Trials. 2019. PMID: 30572160 Clinical Trial.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI. Fava M, et al. Among authors: mathew sj. Mol Psychiatry. 2020 Jul;25(7):1592-1603. doi: 10.1038/s41380-018-0256-5. Epub 2018 Oct 3. Mol Psychiatry. 2020. PMID: 30283029 Free PMC article.
A quality improvement programme to reduce hospital-acquired pressure injuries.
Gupta P, Shiju S, Chacko G, Thomas M, Abas A, Savarimuthu I, Omari E, Al-Balushi S, Jessymol P, Mathew S, Quinto M, McDonald I, Andrews W. Gupta P, et al. Among authors: mathew s. BMJ Open Qual. 2020 Jul;9(3):e000905. doi: 10.1136/bmjoq-2019-000905. BMJ Open Qual. 2020. PMID: 32727869 Free PMC article.
Reply.
Nyhus MØ, Mathew S, Salvesen Ø, Salvesen KÅ, Stafne S, Volløyhaug I. Nyhus MØ, et al. Among authors: mathew s. Ultrasound Obstet Gynecol. 2020 Jul;56(1):121-122. doi: 10.1002/uog.22114. Ultrasound Obstet Gynecol. 2020. PMID: 32608565 Free article. No abstract available.
LncRNA VEAL2 regulates PRKCB2 to modulate endothelial permeability in diabetic retinopathy.
Sehgal P, Mathew S, Sivadas A, Ray A, Tanwar J, Vishwakarma S, Ranjan G, Shamsudheen KV, Bhoyar RC, Pateria A, Leonard E, Lalwani M, Vats A, Pappuru RR, Tyagi M, Jakati S, Sengupta S, B K B, Chakrabarti S, Kaur I, Motiani RK, Scaria V, Sivasubbu S. Sehgal P, et al. Among authors: mathew s. EMBO J. 2021 Aug 2;40(15):e107134. doi: 10.15252/embj.2020107134. Epub 2021 Jun 28. EMBO J. 2021. PMID: 34180064 Free PMC article.
1,351 results